المؤلفون: Kanhai, KMS, Goulooze, SC, Stevens, J, Hay, JL, Dent, G, Verma, A, Hankemeier, T, Boer, T, Meijering, H, Chavez, JC, Cohen, AF, Groeneveld, GJ

المصدر: CTS: Clinical & Translational Science; Dec2016, Vol. 9 Issue 6, p321-327, 7p

مصطلحات موضوعية: GALACTOSYLCERAMIDES, CEREBROSPINAL fluid examination, DEUTERIUM, MYELINATION, MASS spectrometry

المؤلفون: Upadhyay, PJ, Vet, NJ, Goulooze, SC, Krekels, EHJ, de Wildt, SN, Knibbe, CAJ

المصدر: Archives of Disease in Childhood; 2019, Vol. 104 Issue: 6 pe57-e57, 1p

المؤلفون: Krekels, EHJ, Va¨litalo, PAJ, Goulooze, SC, de Kluis, T, van Dijk, M, Simons, SHP, Tibboel, D, Knibbe, CAJ

المصدر: Archives of Disease in Childhood; 2019, Vol. 104 Issue: 6 pe15-e15, 1p

المؤلفون: Goulooze SC; LAP&P Consultants BV, Leiden, The Netherlands., Snelder N; LAP&P Consultants BV, Leiden, The Netherlands.

المصدر: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jul 16. Date of Electronic Publication: 2024 Jul 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE

المؤلفون: Wu Y; Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, The Netherlands., Allegaert K; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Development and Regeneration, and Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Flint RB; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Pediatrics, Division of Neonatology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands., Goulooze SC; Leiden Experts On Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Välitalo PAJ; School of Pharmacy, University of Eastern Finland, Yliopistonranta 1 C, 70210, Kuopio, Finland.; Finnish Medicines Agency, Hallituskatu 12-14, 70100, Kuopio, Finland., de Hoog M; Department of Neonatal and Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands., Mulla H; Department of Pharmacy, University Hospitals of Leicester, Glenfield Hospital, Leicester, LE39QP, England., Sherwin CMT; Department of Pediatrics, Wright State University Boonshoft School of Medicine/Dayton Children's Hospital, One Children's Plaza, Dayton, OH, USA., Simons SHP; Department of Pediatrics, Division of Neonatology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands., Krekels EHJ; Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, The Netherlands.; Certara Inc, Princeton, NJ, USA., Knibbe CAJ; Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, The Netherlands.; Department of Pediatrics, Division of Neonatology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands.; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands., Völler S; Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, The Netherlands. s.voller@lacdr.leidenuniv.nl.; Department of Pediatrics, Division of Neonatology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands. s.voller@lacdr.leidenuniv.nl.

المصدر: Pharmaceutical research [Pharm Res] 2024 Apr; Vol. 41 (4), pp. 637-649. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-904X (Electronic) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res Subsets: MEDLINE

مواضيع طبية MeSH: Inulin* , Anti-Bacterial Agents*, Infant, Newborn ; Child ; Humans ; Glomerular Filtration Rate ; Vancomycin ; Birth Weight ; Creatinine

المؤلفون: Eissing T; Bayer AG, Pharmaceuticals R&D, Pharmacometrics, Leverkusen, Germany., Goulooze SC; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., van den Berg P; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., van Noort M; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Ruppert M; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Snelder N; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Garmann D; Bayer AG, Pharmaceuticals R&D, Pharmacometrics, Leverkusen, Germany., Lippert J; Bayer AG, Pharmaceuticals R&D, Pharmacometrics, Leverkusen, Germany., Heinig R; Bayer AG, Pharmaceuticals R&D, Clinical Pharmacology, Wuppertal, Germany., Brinker M; Bayer AG, Pharmaceuticals R&D, Clinical Development, Wuppertal, Germany., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Mar; Vol. 26 (3), pp. 924-936. Date of Electronic Publication: 2023 Nov 30.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy , Diabetic Nephropathies* , Naphthyridines* , Renal Insufficiency, Chronic*/complications , Renal Insufficiency, Chronic*/drug therapy, Humans ; Potassium/therapeutic use ; Double-Blind Method

المؤلفون: Goulooze SC; LAP&P Consultants BV, Leiden, The Netherlands., Vis PW; LAP&P Consultants BV, Leiden, The Netherlands., Krekels EHJ; Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Knibbe CAJ; Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands.

المصدر: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2023 Jul-Dec; Vol. 16 (12), pp. 1201-1209. Date of Electronic Publication: 2023 Dec 09.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Models, Biological* , Drug Development*, Adult ; Child ; Humans ; Dose-Response Relationship, Drug

المؤلفون: Engbers AGJ; Division of Systems Biomedicine and Pharmacology, LACDR, Leiden University, Leiden, The Netherlands.; Division of Neonatology, Department of Paediatrics, Erasmus UMC - Sophia Children's Hospital, Rotterdam, The Netherlands., Völler S; Division of Systems Biomedicine and Pharmacology, LACDR, Leiden University, Leiden, The Netherlands.; Pharmacy, LACDR, Leiden University, Leiden, The Netherlands., Flint RB; Division of Neonatology, Department of Paediatrics, Erasmus UMC - Sophia Children's Hospital, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Goulooze SC; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., de Klerk J; Division of Neonatology, Department of Paediatrics, Erasmus UMC - Sophia Children's Hospital, Rotterdam, The Netherlands., Krekels EHJ; Division of Systems Biomedicine and Pharmacology, LACDR, Leiden University, Leiden, The Netherlands., van Dijk M; Department of Pediatric Surgery, Erasmus UMC - Sophia Children's Hospital, Rotterdam, The Netherlands., Willemsen SP; Division of Neonatology, Department of Biostatistics, Erasmus UMC - Sophia Children's Hospital, Rotterdam, The Netherlands., Reiss IKM; Division of Neonatology, Department of Paediatrics, Erasmus UMC - Sophia Children's Hospital, Rotterdam, The Netherlands., Knibbe CAJ; Division of Systems Biomedicine and Pharmacology, LACDR, Leiden University, Leiden, The Netherlands.; Division of Neonatology, Department of Paediatrics, Erasmus UMC - Sophia Children's Hospital, Rotterdam, The Netherlands.; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands., Simons SHP; Division of Neonatology, Department of Paediatrics, Erasmus UMC - Sophia Children's Hospital, Rotterdam, The Netherlands.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Aug; Vol. 112 (2), pp. 307-315. Date of Electronic Publication: 2022 May 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Ductus Arteriosus, Patent*/drug therapy, Birth Weight ; Gestational Age ; Humans ; Ibuprofen/adverse effects ; Infant, Newborn ; Infant, Premature

المؤلفون: Goulooze SC; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Heerspink HJL; Department Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van Noort M; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Snelder N; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Brinker M; Bayer AG, Pharmaceuticals R&D, Clinical Development, Leverkusen, Germany., Lippert J; Bayer AG, Pharmaceuticals R&D, Pharmacometrics, Building B106, Room 205, 51368, Leverkusen, Germany., Eissing T; Bayer AG, Pharmaceuticals R&D, Pharmacometrics, Building B106, Room 205, 51368, Leverkusen, Germany. thomas.eissing@bayer.com.

المصدر: Clinical pharmacokinetics [Clin Pharmacokinet] 2022 Jul; Vol. 61 (7), pp. 1013-1025. Date of Electronic Publication: 2022 May 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy , Renal Insufficiency*/complications , Renal Insufficiency, Chronic*/drug therapy , Sodium-Glucose Transporter 2 Inhibitors*, Glomerular Filtration Rate ; Humans ; Mineralocorticoid Receptor Antagonists/pharmacology ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Naphthyridines

المؤلفون: Goulooze SC; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Snelder N; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Seelmann A; Bayer AG, Pharmaceuticals R&D, Pharmacometrics, Leverkusen/Wuppertal/Berlin, Germany., Horvat-Broecker A; Bayer AG, Pharmaceuticals R&D, Pharmacovigilance, Wuppertal, Germany., Brinker M; Bayer AG, Pharmaceuticals R&D, Clinical Development, Wuppertal/Berlin, Germany., Joseph A; Bayer AG, Pharmaceuticals R&D, Clinical Development, Wuppertal/Berlin, Germany., Garmann D; Bayer AG, Pharmaceuticals R&D, Pharmacometrics, Leverkusen/Wuppertal/Berlin, Germany., Lippert J; Bayer AG, Pharmaceuticals R&D, Pharmacometrics, Leverkusen/Wuppertal/Berlin, Germany., Eissing T; Bayer AG, Pharmaceuticals R&D, Pharmacometrics, Leverkusen/Wuppertal/Berlin, Germany. thomas.eissing@bayer.com.

المصدر: Clinical pharmacokinetics [Clin Pharmacokinet] 2022 Mar; Vol. 61 (3), pp. 451-462. Date of Electronic Publication: 2021 Nov 17.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Hyperkalemia*/chemically induced , Hyperkalemia*/drug therapy , Hyperkalemia*/epidemiology , Renal Insufficiency, Chronic*/drug therapy, Female ; Humans ; Male ; Mineralocorticoid Receptor Antagonists/adverse effects ; Naphthyridines ; Potassium